BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19377925)

  • 1. Chemotherapy-associated thrombosis.
    Ashrani AA; Rajkumar SV
    Cancer Treat Res; 2009; 148():181-206. PubMed ID: 19377925
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant human erythropoietin and the risk of thrombosis in patients receiving thalidomide for multiple myeloma.
    Galli M; Elice F; Crippa C; Comotti B; Rodeghiero F; Barbui T
    Haematologica; 2004 Sep; 89(9):1141-2. PubMed ID: 15377478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombosis in multiple myeloma.
    Zangari M; Elice F; Fink L; Tricot G
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):307-15. PubMed ID: 17338651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathophysiology of chemotherapy-associated thrombosis].
    Lechner D; Weltermann A
    Hamostaseologie; 2009 Jan; 29(1):112-20. PubMed ID: 19151860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombosis in childhood cancer.
    Allen GA; Bhat R
    Cancer Treat Res; 2009; 148():223-42. PubMed ID: 19377927
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of venous thrombosis.
    Lee AY
    Cancer Treat Res; 2009; 148():243-57. PubMed ID: 19377928
    [No Abstract]   [Full Text] [Related]  

  • 7. Overview of cancer and thrombosis.
    Matzdorff AC; Green D
    Cancer Treat Res; 2009; 148():83-94. PubMed ID: 19377920
    [No Abstract]   [Full Text] [Related]  

  • 8. Thalidomide-dexamethasone as up-front therapy for patients with newly diagnosed multiple myeloma: thrombophilic alterations, thrombotic complications, and thromboprophylaxis with low-dose warfarin.
    Cini M; Zamagni E; Valdré L; Palareti G; Patriarca F; Tacchetti P; Legnani C; Catalano L; Masini L; Tosi P; Gozzetti A; Cavo M
    Eur J Haematol; 2010 Jun; 84(6):484-92. PubMed ID: 20192986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of thrombotic disorders in cancer patients undergoing chemotherapy.
    Levine MN
    Thromb Haemost; 1997 Jul; 78(1):133-6. PubMed ID: 9198142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications from vascular disrupting agents and angiogenesis inhibitors: aberrant control of hemostasis and thrombosis.
    van Heeckeren WJ; Sanborn SL; Narayan A; Cooney MM; McCrae KR; Schmaier AH; Remick SC
    Curr Opin Hematol; 2007 Sep; 14(5):468-80. PubMed ID: 17934353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalidomide and thrombosis. A meta-analysis.
    El Accaoui RN; Shamseddeen WA; Taher AT
    Thromb Haemost; 2007 Jun; 97(6):1031-6. PubMed ID: 17549307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiological considerations to thrombophilia in the treatment of multiple myeloma with thalidomide and derivates.
    Gieseler F
    Thromb Haemost; 2008 Jun; 99(6):1001-7. PubMed ID: 18521500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombophilia and cancer.
    Horowitz N; Brenner B
    Pathophysiol Haemost Thromb; 2008; 36(3-4):131-6. PubMed ID: 19176986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood coagulation and cancer: thrombosis and survival, clinical relevance and impact. An introduction.
    Vestjens JH; Sassen S; Prins MH
    Pathophysiol Haemost Thromb; 2008; 36(3-4):113-21. PubMed ID: 19176984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenesis inhibitors suffer new setback.
    Garber K
    Nat Biotechnol; 2002 Nov; 20(11):1067-8. PubMed ID: 12410239
    [No Abstract]   [Full Text] [Related]  

  • 16. Thrombosis associated with angiogenesis inhibitors.
    Elice F; Rodeghiero F; Falanga A; Rickles FR
    Best Pract Res Clin Haematol; 2009 Mar; 22(1):115-28. PubMed ID: 19285278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for thrombosis in cancer patients.
    Ashrani AA; Heit JA
    Cancer Treat Res; 2009; 148():95-114. PubMed ID: 19377921
    [No Abstract]   [Full Text] [Related]  

  • 18. Thalidomide and thrombosis.
    Mehta P
    Clin Adv Hematol Oncol; 2003 Aug; 1(8):464-5. PubMed ID: 16258433
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypercoagulable states in patients with multiple myeloma can affect the thalidomide-associated venous thromboembolism.
    Talamo GP; Ibrahim S; Claxton D; Tricot GJ; Fink LM; Zangari M
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):337-9. PubMed ID: 19367157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Corticosteroids in oncology].
    Cleton FJ
    Ned Tijdschr Geneeskd; 1977 Oct; 121(43):1715-20. PubMed ID: 270013
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.